Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

371.18
Delayed Data
As of Feb 17
 -1.84 / -0.49%
Today’s Change
325.35
Today|||52-Week Range
452.96
+1.11%
Year-to-Date
Amgen Shows a Bullish Breakout
Feb 16 / TheStreet.com - Paid Partner Content
A Big Corporate Tax Boost for Big Spenders?
Feb 14 / TheStreet.com - Paid Partner Content
Bullish Momentum for Regeneron
Feb 15 / TheStreet.com - Paid Partner Content
3 Beaten-Down Stocks Ready to Bounce Back
Feb 10 / MotleyFool.com - Paid Partner Content
Drug Stocks Q4 Earnings Slated for Feb 16: ALXN, ZTS & More
Feb 15 / Zacks.com - Paid Partner Content
Regeneron (REGN) Misses on Q4 Earnings & Sales, View Bleak
Feb 09 / Zacks.com - Paid Partner Content
Amgen Looking to Broaden Leukemia Drug Blincyto's Label
Feb 15 / Zacks.com - Paid Partner Content
Regeneron (REGN) Q4 Earnings Misses Estimates
Feb 09 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Regeneron's Praluent to Remain on Market for Now, GILD Present...
Feb 15 / Zacks.com - Paid Partner Content
Regeneron (REGN) Q4 Earnings: Will the Stock Disappoint?
Feb 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close373.02
Today’s open372.42
Day’s range369.30 - 375.00
Volume775,547
Average volume (3 months)950,983
Market cap$39.4B
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+39.49%
Earnings growth (this year)+19.52%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)+18.44%
P/E ratio48.2
Price/Sales8.79
Price/Book8.84

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-1.57-1.20%
BAXBaxter International...+0.31+0.63%
ZTSZoetis Inc-0.27-0.51%
SHPGShire+2.38+1.33%
Data as of 4:01pm ET, 02/17/2017

Financials

Next reporting dateMay 5, 2017
EPS forecast (this quarter)$3.10
Annual revenue (last year)$4.9B
Annual profit (last year)$895.5M
Net profit margin18.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Scientific Officer
George Damis Yancopoulos
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts


Search for Jobs